Tag: Sickle-Cell Anemia
Lung Function Stable Three Years After Hematopoietic Cell Transplant in Sickle Cell
Improvement seen in diffusing capacity of the lungs for carbon monoxide and in the six-minute walk test
Exposure to Hydroxyurea Does Not Impact Ovarian Reserve in Sickle Cell
For girls with sickle cell disease, density of growing follicles was marginally lower in hydroxyurea group after adjustment for age
Clinical Report Addresses Management of Sickle Cell Disease in Children, Teens
Comprehensive care from pediatric primary care provider and multidisciplinary specialist team needed
Longer Transfer Gap to Adult Care Increases Inpatient Encounters in Sickle Cell Disease
Young adults with transfer gaps of six months or more have increase in rate of hospitalization, ED encounters
Exa-Cel Eliminates Vaso-Occlusive Crises in Most Sickle Cell Patients
97 percent of patients were free from vaso-occlusive crises for at least 12 consecutive months
Crude Sickle Cell Birth Prevalence 28.54 per 10,000 in Non-Hispanic Blacks
Two-thirds of mothers of newborns with SCD live in counties with high, very high levels of social vulnerability
Many Children With Sickle Cell Anemia Do Not Meet Quality Indicators
Rates of receipt of recommended antibiotic prophylaxis and annual transcranial Doppler low
Gene Therapy for Sickle Cell Disease Likely Cost-Effective at <$2 Million
Incremental cost-effectiveness ratios were $126,000 and $281,000 per QALY for two simulation models from a societal perspective
COVID-19 Vaccine Uptake Lagging in Patients With Sickle Cell Disease
In Michigan, those with sickle cell disease have half the coverage rate of people without sickle cell disease
First Gene-Editing Therapies for Sickle Cell Disease Approved by FDA
In both therapies, stem cells are removed from a patient's blood for treatment
